Genaissance Pharmaceuticals other research news

Genaissance received four SBIR grants totaling $2.4 million to fund its research on gene profiling combined with pharmaceutical chemistry.

Read the full 198 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE